Pharmaceutical - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

226 to 250 of 656 results

New Zealand medicines and vaccines industry bodies merge

31-07-2013

Patients in New Zealand could get better access to new and improved vaccines following a merger between…

Mergers & AcquisitionsPharmaceutical

Cubist Pharma signs two acquisition deals in one day

31-07-2013

In what must have been a busy day for US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) announced not…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMergers & AcquisitionsOptimer PharmaceuticalsPharmaceuticaltedizolidTrius Therapeutics

Health care M&A spending grows in 2nd-qtr 2013, says Irving Levin

30-07-2013

Health care merger and acquisition activity strengthened in the second quarter of 2013. (View full video:…

BiotechnologyMergers & AcquisitionsPharmaceutical

Pfizer to separate business into three units: will this lead to spin-outs?

29-07-2013

Moving in a direction already advocated by several analysts, US pharma behemoth Pfizer (NYSE: PFE) today…

GenericsManagementMergers & AcquisitionsPfizerPharmaceutical

Elan board agrees $8.6 billion takeover bid

29-07-2013

US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp…

ElanGenericsMergers & AcquisitionsPerrigoPharmaceuticalTysabri

Recordati acquires Tunisian drugmaker

25-07-2013

Italian drugmaker Recordati (RC: MI) has singed announces the signature of the agreements covering the…

GenericsMergers & AcquisitionsOpalia PharmaPharmaceuticalRecordati

Elan posts financials, as it explores sale of the company

25-07-2013

Ireland-based Elan Corp (NYSE:ELN) today reported its second quarter 2013 financial results, showing…

ElanFinancialMergers & AcquisitionsPharmaceuticalTysabri

EU Commission puts conditions on Baxter's acquisition of Gambro

23-07-2013

The European Commission has authorized the proposed $4 billion acquisition of privately-held Swedish…

Baxter InternationalGambroMergers & AcquisitionsPharmaceutical

Ipsen makes acquisition and signs R&D deal with Harvard

15-07-2013

French drugmaker Ipsen (Euronext: IPN) has acquired UK life sciences company Syntaxin for an upfront…

EuropeIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSyntaxin

Mitsubishi Tanabe to acquire 60% of Canada's Medicago in $172 million deal

12-07-2013

Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has reached agreement to acquire 60% of Canada's…

MedicagoMergers & AcquisitionsMitsubishi TanabePharmaceuticalVaccines

Italy's Chiesi gains rights to uniQure's Glybera

12-07-2013

Netherlands-based venture capital backed human gene therapy firm uniQure has signed collaboration agreements…

BiotechnologyChiesi FarmaceuticiGlyberaLicensingMergers & AcquisitionsPharmaceuticaluniQure

Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma

10-07-2013

Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

Fresenius gets US FDA warning over Indian plant; divests biotech unit

09-07-2013

Germany-based Fresenius Kabi has received a warning letter from the US Food and Drug Administration in…

Fresenius BiotechFresenius KabiMergers & AcquisitionsNeoPharmPharmaceuticalRegulationRemovab

XOMA transfers perindopril franchise rights to Symplmed

08-07-2013

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has transferred US development and commercialization…

Cardio-vascularLicensingMergers & AcquisitionsperindoprilPharmaceuticalServierSymplmedXOMA Corp

South Africa's Adcock Ingram confirms takeover bid from CFR Pharma

04-07-2013

In what was described as a "cautionary" statement, South Africa's largest drugmaker Adcock Ingram (AIP:…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Pharmstandard may sell its non-Rx business for $2.5 billion; AbbVie Russian plans

02-07-2013

Pharmstandard, Russia's largest drug producer, is considering selling its production of non-prescription…

AbbVieEuropeMergers & AcquisitionsPharmaceuticalPharmstandardProductionR-Pharma

Pfizer details final spinoff of Zoetis

20-06-2013

US pharma behemoth Pfizer (NYSE: PFE) has announced the final exchange ratio of 0.9898 for the animal…

FinancialMergers & AcquisitionsPharmaceutical

Royalty pulls plug on Elan buy (for now?); analysts' view on what comes next

19-06-2013

In the ongoing hostile takeover saga, US private equity firm Royalty Pharma has withdrawn its request…

ElanMergers & AcquisitionsPharmaceuticalRoyalty Pharma

Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site

19-06-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

AOP Orphan spins off stake in Activartis as Elan shareholders vote down acquisition

18-06-2013

In the wake of yesterday's shareholders vote against Irish drugmaker Elan Corp's (NYSE: ELN) planned…

ActivartisAOP OrphanElanMergers & AcquisitionsOncologyPharmaceutical

226 to 250 of 656 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top